Adenovirus-mediated expression of mutated forkhead human transcription like-1 suppresses tumor growth in a mouse melanoma xenograft model

References

• Miller AJ, Mihm MC Jr.. Melanoma. N Engl J Med 2006; 355:51 - 65; http://dx.doi.org/10.1056/NEJMra052166; PMID: 16822996
   PubMed Web of Science ®Google Scholar
• Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, et al. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol 2007; 143:21 - 8; http://dx.doi.org/10.1001/archderm.143.1.21; PMID: 17224538
   PubMed Web of Science ®Google Scholar
• Geserick P, Drewniok C, Hupe M, Haas TL, Diessenbacher P, Sprick MR, et al. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Oncogene 2008; 27:3211 - 20; http://dx.doi.org/10.1038/sj.onc.1210985; PMID: 18084329
   PubMed Web of Science ®Google Scholar
• Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH, et al. Frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res 2002; 12:263 - 70; http://dx.doi.org/10.1097/00008390-200206000-00010; PMID: 12140383
   PubMed Web of Science ®Google Scholar
• Fu Z, Tindall DJ. FOXOs, cancer and regulation of apoptosis. Oncogene 2008; 27:2312 - 9; http://dx.doi.org/10.1038/onc.2008.24; PMID: 18391973
   PubMed Web of Science ®Google Scholar
• Dansen TB, Burgering BM. Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol 2008; 18:421 - 9; http://dx.doi.org/10.1016/j.tcb.2008.07.004; PMID: 18715783
   PubMed Web of Science ®Google Scholar
• Arimoto-Ishida E, Ohmichi M, Mabuchi S, Takahashi T, Ohshima C, Hayakawa J, et al. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Endocrinology 2004; 145:2014 - 22; http://dx.doi.org/10.1210/en.2003-1199; PMID: 14701673
   PubMed Web of Science ®Google Scholar
• Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002; 277:47928 - 37; http://dx.doi.org/10.1074/jbc.M207509200; PMID: 12351634
   PubMed Web of Science ®Google Scholar
• Lau CJ, Koty Z, Nalbantoglu J. Differential response of glioma cells to FOXO1-directed therapy. Cancer Res 2009; 69:5433 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-08-4540; PMID: 19549905
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Souza V, Hao HY, Montes de Oca-Luna R, Dong YB, Zhou HS, et al. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol Ther 2006; 5:875 - 83; http://dx.doi.org/10.4161/cbt.5.7.2911; PMID: 16861905
   PubMed Web of Science ®Google Scholar
• Yang JY, Xia W, Hu MC. Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. Int J Oncol 2006; 29:643 - 8; PMID: 16865280
   PubMed Web of Science ®Google Scholar
• Suhara T, Kim HS, Kirshenbaum LA, Walsh K. Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell Biol 2002; 22:680 - 91; http://dx.doi.org/10.1128/MCB.22.2.680-691.2002; PMID: 11756562
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96:857 - 68; http://dx.doi.org/10.1016/S0092-8674(00)80595-4; PMID: 10102273
   PubMed Web of Science ®Google Scholar
• Raisova M, Bektas M, Wieder T, Daniel P, Eberle J, Orfanos CE, et al. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett 2000; 473:27 - 32; http://dx.doi.org/10.1016/S0014-5793(00)01491-5; PMID: 10802053
   PubMed Web of Science ®Google Scholar
• Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, Orfanos CE, et al. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Oncogene 2003; 22:9131 - 41; http://dx.doi.org/10.1038/sj.onc.1207228; PMID: 14668794
   PubMed Web of Science ®Google Scholar
• Bauer TW, Gutierrez M, Dudrick DJ, Li J, Blair IA, Menon C, et al. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan. Surgery 2003; 133:420 - 8; http://dx.doi.org/10.1067/msy.2003.113; PMID: 12717360
   PubMed Web of Science ®Google Scholar
• Canter RJ, Zhou R, Kesmodel SB, Zhang Y, Heitjan DF, Glickson JD, et al. Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma. Ann Surg Oncol 2004; 11:265 - 73; http://dx.doi.org/10.1245/ASO.2004.05.019; PMID: 14993021
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 2010; 12:665 - 75; http://dx.doi.org/10.1038/ncb2069; PMID: 20543840
   PubMed Web of Science ®Google Scholar
• LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG. IAP-targeted therapies for cancer. Oncogene 2008; 27:6252 - 75; http://dx.doi.org/10.1038/onc.2008.302; PMID: 18931692
   PubMed Web of Science ®Google Scholar
• Hilmi C, Larribere L, Deckert M, Rocchi S, Giuliano S, Bille K, et al. Involvement of FKHRL1 in melanoma cell survival and death. Pigment Cell Melanoma Res 2008; 21:139 - 46; http://dx.doi.org/10.1111/j.1755-148X.2008.00440.x; PMID: 18426407
   PubMed Web of Science ®Google Scholar
• Ko SH, Ueno T, Yoshimoto Y, Yoo JS, Abdel-Wahab OI, Abdel-Wahab Z, et al. Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity. Clin Cancer Res 2006; 12:289 - 97; http://dx.doi.org/10.1158/1078-0432.CCR-05-0210; PMID: 16397054
   PubMed Web of Science ®Google Scholar
• Dong YB, Yang HL, Elliott MJ, McMasters KM. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Cancer Res 2002; 62:1776 - 83; PMID: 11912154
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Garcia-Garcia A, Hao H, Rao XM, Montes de Oca-Luna R, Zhou HS, et al. Adenovirus-mediated expression of truncated E2F-1 suppresses tumor growth in vitro and in vivo. Cancer 2010; 116:4420 - 32; http://dx.doi.org/10.1002/cncr.25322; PMID: 20549818
   PubMed Web of Science ®Google Scholar